BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20619170)

  • 21. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
    Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
    Bone Marrow Transplant; 2002 Apr; 29(8):639-46. PubMed ID: 12180107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the implementation of a Joint Accreditation Committee of the International Society for Cellular Therapy and European Group for Blood and Marrow Transplantation acreditation in a clinical program of hematopoietic progenitor cell transplantation].
    Ferrà C; Jiménez-Lorenzo MJ; Feliu E; Ribera JM;
    Med Clin (Barc); 2011 Jun; 137(3):126-30. PubMed ID: 20303546
    [No Abstract]   [Full Text] [Related]  

  • 23. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [JACIE: from guidelines to clinical practice and continuous quality improvement, the Léon-Bérard cancer center experience].
    Donot PE
    Bull Cancer; 2009; 96(7):797-804. PubMed ID: 19592332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).
    Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA;
    Bone Marrow Transplant; 2020 Feb; 55(2):283-306. PubMed ID: 31558790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
    Jessop H; Farge D; Saccardi R; Alexander T; Rovira M; Sharrack B; Greco R; Wulffraat N; Moore J; Kazmi M; Badoglio M; Adams G; Verhoeven B; Murray J; Snowden JA
    Bone Marrow Transplant; 2019 Jul; 54(7):933-942. PubMed ID: 30705338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standards of stem cell transplantation: Part I: the accreditation of paediatric stem cell transplantation centres within the EBMT; Part II: intensive care units in paediatric stem cell transplantation; Part III: informed consent and sibling donor issues.
    Cornish J; Peters C
    Bone Marrow Transplant; 2001 Aug; 28 Suppl 1():S4-5. PubMed ID: 11571522
    [No Abstract]   [Full Text] [Related]  

  • 28. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.
    Gratwohl A; Brand R; Niederwieser D; Baldomero H; Chabannon C; Cornelissen J; de Witte T; Ljungman P; McDonald F; McGrath E; Passweg J; Peters C; Rocha V; Slaper-Cortenbach I; Sureda A; Tichelli A; Apperley J
    J Clin Oncol; 2011 May; 29(15):1980-6. PubMed ID: 21483006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standards for specialist units undertaking blood and marrow stem cell transplants--recommendations from the EBMT. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
    Link H; Schmitz N; Gratwohl A; Goldman J
    Bone Marrow Transplant; 1995 Dec; 16(6):733-6. PubMed ID: 8750261
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).
    Bacigalupo A
    Bone Marrow Transplant; 2000 Apr; 25(8):803-5. PubMed ID: 10808199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
    Sanchez-Guijo F; Vives J; Ruggeri A; Chabannon C; Corbacioglu S; Dolstra H; Farge D; Gagelmann N; Horgan C; Kuball J; Neven B; Rintala T; Rocha V; Sanchez-Ortega I; Snowden JA; Zwaginga JJ; Gnecchi M; Sureda A
    Cytotherapy; 2024 Jul; 26(7):681-685. PubMed ID: 38416085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in hematopoietic stem cell transplant activity in Lebanon.
    Bazarbachi A; Zahreddine A; Massoud R; El Cheikh J; Hanna C; Nasr F; Abboud M; Ibrahim A
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
    Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
    Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
    Hayden PJ; Roddie C; Bader P; Basak GW; Bonig H; Bonini C; Chabannon C; Ciceri F; Corbacioglu S; Ellard R; Sanchez-Guijo F; Jäger U; Hildebrandt M; Hudecek M; Kersten MJ; Köhl U; Kuball J; Mielke S; Mohty M; Murray J; Nagler A; Rees J; Rioufol C; Saccardi R; Snowden JA; Styczynski J; Subklewe M; Thieblemont C; Topp M; Ispizua ÁU; Chen D; Vrhovac R; Gribben JG; Kröger N; Einsele H; Yakoub-Agha I
    Ann Oncol; 2022 Mar; 33(3):259-275. PubMed ID: 34923107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis.
    Zahnd D; Leibundgut K; Zenhäusern R; Pabst T; Fontana S; Schneider R; Tobler A; Zwicky C
    Bone Marrow Transplant; 2004 Nov; 34(10):847-53. PubMed ID: 15517005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of COVID-19 Pandemic on Hematopoietic Stem Cell Transplant Activity: Experience of a JACIE-Accredited Center.
    Kozanoğlu I; Kursun E; Demiroglu YZ; Sen N; Kis C; Yeşilagaç H; Pocan G; Gul E; Alıskan HE; Boga C
    Exp Clin Transplant; 2022 Oct; ():. PubMed ID: 36259608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.